198 related articles for article (PubMed ID: 35039759)
1. Association between Arsenic Level, Gene Expression in Asian Population, and In Vitro Carcinogenic Bladder Tumor.
Singhal S; Ruprecht NA; Sens D; Tavakolian K; Gardner KL; Singhal SK
Oxid Med Cell Longev; 2022; 2022():3459855. PubMed ID: 35039759
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles to analyze the anticancer and carcinogenic effects of arsenic in bladder cancer.
Han X; Zhang T; Ma Q; Chang R; Xin S; Yu Q; Zhang G; Wang Y
Am J Transl Res; 2023; 15(10):5984-5996. PubMed ID: 37969188
[TBL] [Abstract][Full Text] [Related]
3. Identification of interspecies concordance of mechanisms of arsenic-induced bladder cancer.
Sen B; Wolf DC; Turpaz Y; Bugrim A; Retief J; Hester SD
Toxicol In Vitro; 2007 Dec; 21(8):1513-29. PubMed ID: 17720352
[TBL] [Abstract][Full Text] [Related]
4. MiADMSA ameliorate arsenic induced urinary bladder carcinogenesis in vivo and in vitro.
Sathua K; Srivastava S; Flora SJS
Biomed Pharmacother; 2020 Aug; 128():110257. PubMed ID: 32474354
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors.
Wei M; Wanibuchi H; Morimura K; Iwai S; Yoshida K; Endo G; Nakae D; Fukushima S
Carcinogenesis; 2002 Aug; 23(8):1387-97. PubMed ID: 12151359
[TBL] [Abstract][Full Text] [Related]
6. Arsenic-related chromosomal alterations in bladder cancer.
Moore LE; Smith AH; Eng C; Kalman D; DeVries S; Bhargava V; Chew K; Moore D; Ferreccio C; Rey OA; Waldman FM
J Natl Cancer Inst; 2002 Nov; 94(22):1688-96. PubMed ID: 12441324
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24.
Cao Y; Yu SL; Wang Y; Guo GY; Ding Q; An RH
Tumour Biol; 2011 Feb; 32(1):179-88. PubMed ID: 20857258
[TBL] [Abstract][Full Text] [Related]
8. Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
Marsit CJ; Karagas MR; Danaee H; Liu M; Andrew A; Schned A; Nelson HH; Kelsey KT
Carcinogenesis; 2006 Jan; 27(1):112-6. PubMed ID: 15987713
[TBL] [Abstract][Full Text] [Related]
9. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
[TBL] [Abstract][Full Text] [Related]
10. Arsenic and bladder cancer: observations and suggestions.
Radosavljević V; Jakovljević B
J Environ Health; 2008 Oct; 71(3):40-2. PubMed ID: 18990932
[TBL] [Abstract][Full Text] [Related]
11. Impact of arsenic exposure on clinicopathological characteristics of bladder cancer: A comparative study between patients from an arsenic-exposed region and nonexposed reference sites.
Fernández MI; Valdebenito P; Delgado I; Segebre J; Chaparro E; Fuentealba D; Castillo M; Vial C; Barroso JP; Ziegler A; Bustamante A
Urol Oncol; 2020 Feb; 38(2):40.e1-40.e7. PubMed ID: 31630994
[TBL] [Abstract][Full Text] [Related]
12. Proteomic characterization of arsenic and cadmium exposure in bladder cells.
Chen YT; Ou Yang WT; Juang HH; Chen CL; Chen HW; Tsui KH; Chang YH; Tsai CH; Hsueh C; Liao WC
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8578. PubMed ID: 31499585
[TBL] [Abstract][Full Text] [Related]
13. Rationale for selecting exfoliated bladder cell micronuclei as potential biomarkers for arsenic genotoxicity.
Smith AH; Hopenhayn-Rich C; Warner M; Biggs ML; Moore L; Smith MT
J Toxicol Environ Health; 1993; 40(2-3):223-34. PubMed ID: 8230298
[TBL] [Abstract][Full Text] [Related]
14. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water.
Moore LE; Smith AH; Hopenhayn-Rich C; Biggs ML; Kalman DA; Smith MT
Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):31-6. PubMed ID: 8993795
[TBL] [Abstract][Full Text] [Related]
15. A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire.
Lesseur C; Gilbert-Diamond D; Andrew AS; Ekstrom RM; Li Z; Kelsey KT; Marsit CJ; Karagas MR
Toxicol Lett; 2012 Apr; 210(1):100-6. PubMed ID: 22306368
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.
Rager JE; Tilley SK; Tulenko SE; Smeester L; Ray PD; Yosim A; Currier JM; Ishida MC; González-Horta Mdel C; Sánchez-Ramírez B; Ballinas-Casarrubias L; Gutiérrez-Torres DS; Drobná Z; Del Razo LM; García-Vargas GG; Kim WY; Zhou YH; Wright FA; Stýblo M; Fry RC
Chem Res Toxicol; 2015 Jun; 28(6):1144-55. PubMed ID: 26039340
[TBL] [Abstract][Full Text] [Related]
17. Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo.
Zhou P; Kalakonda N; Comenzo RL
Br J Haematol; 2005 Mar; 128(5):636-44. PubMed ID: 15725085
[TBL] [Abstract][Full Text] [Related]
18. Carcinogen exposure and epigenetic silencing in bladder cancer.
Marsit CJ; Karagas MR; Schned A; Kelsey KT
Ann N Y Acad Sci; 2006 Sep; 1076():810-21. PubMed ID: 17119258
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome-wide analysis of changes in the fetal placenta associated with prenatal arsenic exposure in the New Hampshire Birth Cohort Study.
Winterbottom EF; Ban Y; Sun X; Capobianco AJ; Marsit CJ; Chen X; Wang L; Karagas MR; Robbins DJ
Environ Health; 2019 Nov; 18(1):100. PubMed ID: 31752878
[TBL] [Abstract][Full Text] [Related]
20. Identifying arsenic trioxide (ATO) functions in leukemia cells by using time series gene expression profiles.
Yang H; Lin S; Cui J
Gene; 2014 Feb; 535(2):312-7. PubMed ID: 24262935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
